Pacific Defense Awarded Defense Innovation Unit Contract to Deliver Assured PNT 3U Cards for Army and Broader DoD adoption

4 years ago

EL SEGUNDO, Calif.--(BUSINESS WIRE)--#USARMY--Pacific Defense, a leading open systems integrator delivering Modular Open Systems Approach (MOSA) products and mission solutions,…

Australasian Inter-Service Incident Management System (AIIMS) Tecnologies & Tools – Main Players Analysis – 2022 Report – ResearchAndMarkets.com

4 years ago

DUBLIN--(BUSINESS WIRE)--The "Australasian Inter-Service Incident Management System (AIIMS) Tecnologies & Tools - Main Players Analysis - 2022 Report" report has…

Asahi Kasei Starts Selling BR and S-SBR Made Using the Mass-balance Method

4 years ago

— Toward achievement of sustainability — NEW YORK & DÜSSELDORF, Germany & TOKYO--(BUSINESS WIRE)--#asahikasei--Asahi Kasei, a diversified Japanese multinational company,…

ASTER_Wise Solution to Serve the Smart Community in Indonesia

4 years ago

AR/VR interactive caring and epidemic prevention are advanced smart technologies JAKARTA TIMUR, Indonesia--(BUSINESS WIRE)--ASTER_Wise Smart Community Theme Alliance organizes Taiwanese…

City of Tampere: Finland in Co-operation With Japan in Human-Centred Smart Urban Development

4 years ago

TAMPERE, Finland--(BUSINESS WIRE)--#AuroraAI--Tampere, one of Finland's largest cities, is the first in Europe to introduce the Liveable Well-Being City indicators,…

Marinus Pharmaceuticals Announces Collaboration with Tenacia Biotechnology for Ganaxolone Development and Commercialization in China

4 years ago

Collaboration leverages Tenacia’s CNS, R&D, and local market expertise to support expansion of ganaxolone’s development programs and potentially provide additional…

BeiGene Receives European Commission Approval for BRUKINSA® (zanubrutinib) for the Treatment of Adults with Chronic Lymphocytic Leukemia (CLL)

4 years ago

BRUKINSA is the only Bruton’s Tyrosine Kinase (BTK) inhibitor to achieve superiority over IMBRUVICA® (ibrutinib) in relapsed/refractory CLL. BRUKINSA also…

Azura Ophthalmics Announces Positive Results from Phase 2b Clinical Trial of AZR-MD-001 in Meibomian Gland Dysfunction

4 years ago

AZR-MD-001 0.5% meets co-primary efficacy endpoints, making it the first investigational drug to show significant improvements in both signs and…

Genius Group to Announce Third Quarter 2022 Financial Results

4 years ago

SINGAPORE--(BUSINESS WIRE)--$GNS #GNS--Genius Group Limited (“Genius Group” or the “Company”) (NYSE American: GNS), will announce third quarter 2022 financial results…

Alibaba Group Announces September Quarter 2022 Results

4 years ago

HANGZHOU, China--(BUSINESS WIRE)--$BABA #alibaba--Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988, “Alibaba” or “Alibaba Group”) today announced its financial…